CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,000 | -18.2% | 107,299 | +25.4% | 0.00% | – |
| Q2 2022 | $22,000 | -4.3% | 85,592 | +101.6% | 0.00% | – |
| Q1 2022 | $23,000 | +53.3% | 42,453 | +74.1% | 0.00% | – |
| Q4 2021 | $15,000 | -34.8% | 24,384 | +5.9% | 0.00% | – |
| Q3 2021 | $23,000 | 0.0% | 23,035 | +81.5% | 0.00% | – |
| Q2 2021 | $23,000 | -8.0% | 12,691 | +0.6% | 0.00% | – |
| Q1 2021 | $25,000 | -10.7% | 12,619 | -44.5% | 0.00% | – |
| Q4 2020 | $28,000 | -66.3% | 22,738 | -50.4% | 0.00% | – |
| Q3 2020 | $83,000 | -56.1% | 45,867 | +103.6% | 0.00% | – |
| Q2 2020 | $189,000 | +47.7% | 22,528 | -7.3% | 0.00% | – |
| Q1 2020 | $128,000 | – | 24,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
| Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
| IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
| WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
| Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
| Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
| Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
| Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |